Impact of phosphorylated insulin‑like growth factor‑1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy

Cancer Patients ◽

Prognostic Value ◽

Breast Cancer Patients

Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy

Scientific Reports ◽

10.1038/s41598-020-69965-1 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Soong June Bae ◽

Yoon Jin Cha ◽

Changik Yoon ◽

Dooreh Kim ◽

Janghee Lee ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Epidermal Growth

The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients

European Journal of Cancer ◽

10.1016/0959-8049(94)90247-x ◽

1994 ◽

Vol 30 (3) ◽

pp. 307-311 ◽

Cited By ~ 65

Author(s):

Mikael J. Railo ◽

Karl v. Smitten ◽

Fredrika Pekonen

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Prognostic Value ◽

Breast Cancer Patients ◽

Factor I ◽

Follow Up Study ◽

Growth Factor I

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Breast Cancer Research ◽

10.1186/s13058-015-0663-3 ◽

2016 ◽

Vol 18 (1) ◽

Cited By ~ 15

Author(s):

Stefanie de Groot ◽

◽

Ayoub Charehbili ◽

Hanneke W. M. van Laarhoven ◽

Antien L. Mooyaart ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Receptor Expression ◽

Response To Neoadjuvant Chemotherapy

Breast Cancer Patients ◽

Abstract P3-07-54: Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)

10.1158/1538-7445.sabcs15-p3-07-54 ◽

2016 ◽

Author(s):

S de Groot ◽

A Charehbili ◽

HWM van Laarhoven ◽

AL Mooyaart ◽

NG Dekker-Ensink ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Receptor Expression ◽

Response To Neoadjuvant Chemotherapy

Breast Cancer Patients ◽

Steroid receptors and insulin-like growth factor expression in the endometrium of breast cancer patients on tamoxifen compared with controls

European Journal of Cancer ◽

10.1016/s0959-8049(02)80435-x ◽

2002 ◽

Vol 38 (11) ◽

pp. S133

Author(s):

Z Rayter

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Steroid Receptors ◽

Breast Cancer Patients ◽

Factor Expression ◽

Growth Factor Expression

Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-013-1391-7 ◽

2013 ◽

Vol 139 (5) ◽

pp. 837-843 ◽

Cited By ~ 7

Author(s):

Lisa Gallicchio ◽

Ryan MacDonald ◽

Kathy J. Helzlsouer

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Musculoskeletal Pain ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

History Of ◽

History Of Cancer

Changes and Predictive and Prognostic Value of the Mitotic Index, Ki‐67, Cyclin D1, and Cyclo‐oxygenase‐2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

The Oncologist ◽

10.1634/theoncologist.2008-0073 ◽

2008 ◽

Vol 13 (12) ◽

pp. 1235-1245 ◽

Cited By ~ 46

Author(s):

Frédérique Penault‐Llorca ◽

Catherine Abrial ◽

Inès Raoelfils ◽

Philippe Chollet ◽

Anne Cayre ◽

...

Keyword(s):

Breast Cancer ◽

Cyclin D1 ◽

Cancer Patients ◽

Mitotic Index ◽

Prognostic Value ◽

Operable Breast Cancer ◽

Breast Cancer Patients ◽

Ki 67 ◽

Predictive And Prognostic Value

Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05421-7 ◽

2019 ◽

Vol 178 (3) ◽

pp. 497-504 ◽

Cited By ~ 3

Author(s):

Chao Li ◽

Hongwei Fan ◽

Qian Xiang ◽

Ling Xu ◽

Zhuo Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Prognostic Value ◽

Meta Analysis ◽

Breast Cancer Patients ◽

Receptor Status

Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-I in post-menopausal breast cancer patients

Clinical Endocrinology ◽

10.1111/j.1365-2265.1995.tb00555.x ◽

1995 ◽

Vol 43 (6) ◽

pp. 772-772

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Sex Hormones ◽

Sex Hormone Binding Globulin ◽

Breast Cancer Patients ◽

Hormone Binding ◽

Factor I ◽

Post Menopausal

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients

BMC Cancer ◽

10.1186/s12885-018-4822-7 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 8

Author(s):

Ruo-Xi Wang ◽

Sheng Chen ◽

Liang Huang ◽

Zhi-Ming Shao

Keyword(s):

Breast Cancer ◽

Matrix Metalloproteinase ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Prognostic Value ◽

Triple Negative ◽

Breast Cancer Patients ◽

Predictive And Prognostic Value